ArticleOncotarget2016
RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics.
Florian J Sulzmaier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it